Research Reports Initiated on Healthcare Stocks Immunovaccine, Oncolytics Biotech, and Theratechnologies

LONDON, UK / ACCESSWIRE / December 13, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include Immunovaccine, Oncolytics Biotech, and Theratechnologies. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

At the close of the Canadian markets on Monday, December 12, 2016, the Toronto Exchange Composite index ended the trading session at 15,287.70, 0.16% lower from its previous closing price.

The Healthcare Index was also in the red, closing the day at 67.51, down 1.01%.

Active Wall St. has initiated research reports on the following equities: Immunovaccine Inc., (TSX: IMV), Oncolytics Biotech Inc., (TSX: ONC), and Theratechnologies Inc. (TSX: TH). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Immunovaccine Inc.

Halifax, Canada headquartered Immunovaccine Inc.’s stock declined 5.41%, to close the day at $0.70. The stock recorded a trading volume of 35,000 shares. Shares of the company, which develops products based on its proprietary vaccine enhancement platform with a primary focus on T cell activating therapies for cancer, are trading above their 200-day moving average. Moreover, the stock’s 50-day moving average of $0.74 is greater than its 200-day moving average of $0.68. See our research report on IMV.TO at: http://www.activewallst.com/registration-3/?symbol=IMV.

Oncolytics Biotech Inc.

Calgary, Canada headquartered Oncolytics Biotech Inc.’s stock advanced 2.17%, to finish Monday’s session at $0.23 with a total volume of 168,553 shares traded. Shares of the Company, which focuses on the discovery and development of pharmaceutical products for the treatment of cancers, are trading below its 50-day and 200-day moving averages. Oncolytics Biotech’s 200-day moving average of $0.37 is above its 50-day moving average of $0.26. The complimentary research report on ONC.TO at: http://www.activewallst.com/registration-3/?symbol=ONC.

Theratechnologies Inc.

On Monday, shares in Montreal, Canada headquartered Theratechnologies Inc. recorded a trading volume of 279,605 shares, which was higher than their three months average volume of 143,655 shares. The stock ended the day 3.83% lower at $2.76. Shares of the Company, which addresses unmet medical needs in metabolic disorders, are trading below its 50-day and 200-day moving averages. The stock’s 50-day moving average of $3.13 is above its 200-day moving average of $3.09. Get free access to your research report on TH.TO at: http://www.activewallst.com/registration-3/?symbol=TH.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 450956